Abstract:Purpose: The successful development of controlled release formulations for proteins requires that the protein not be denatured during the manufacturing process. The major objective was to develop formulations that stabilize two recombinant human proteins, human growth hormone (rhGH) and interferon-gamma (rhIFN-gamma), at high protein concentrations (> 100 mg/mL) in organic solvents commonly used for microencapsulation, methylene chloride and ethyl acetate. Methods: Several excipients were screened to obtain the maximum solubility of each protein. These formulations (aqueous, lyophilized, milled, spray dried, or isoelectric precipitate) were then rapidly screened by emulsification in the organic solvent followed by recovery into excess buffer. Additional screening was performed with solid protein that was suspended in the organic solvent and then recovered with excess buffer. The recovery of native protein was determined by native size exclusion chromatography (SEC-HPLC) and circular dichroism (CD). The selected formulations were encapsulated in polylactic-coglycolic acid (PLGA) microspheres by either water-in-oil-in-water (W/O/W) or solid-in-oil-in-water (S/O/W) methods. The initial protein released from the microspheres incubated at physiological conditions was analyzed by SEC-HPLC, CD, and biological assays. Results: The stability of a given formulation in the rapid screening method correlated well with stability during encapsulation in PLGA microspheres. Formulations of rhGH containing Tween 20 or 80 resulted in lower recovery of native protein, while trehalose and mannitol formulations (phosphate buffer, pH 8.0) yielded complete recovery of native rhGH. Other additives such as carboxymethyl cellulose, gelatin, and dextran 70 were not effective stabilizers, and polyethylene glycol provided some stabilization of rhGH. Trehalose/rhGH (1:4 mass ratio) and mannitol/rhGH (1:2 mass ratio) formulations (potassium phosphate buffer, pH 8.0) were lyophilized, reconstituted to 200 and 400 mg/mL rhGH, respectively, and then encapsulated in PLGA microspheres. The protein was released from these microspheres in its native state. Lyophilized formulations of rhGH yielded analogous results indicating the ability of trehalose and mannitol to stabilize the protein. Small solid particles of rhGH generated by spray drying (both air and freeze-drying) formulations containing Tween 20 or PEG were stable in ethyl acetate, but not methylene chloride. Similar results were also obtained with rhIFN-gamma (137 mg/mL in succinate buffer, pH 5.0), where both mannitol and trehalose were observed to stabilize the protein during exposure to the organic solvents resulting in the release of native rhIFN-gamma from PLGA microspheres. Conclusions: The rapid screening method allowed the development of stable concentrated protein solutions or solid protein formulations that could be successfully encapsulated in PLGA microspheres. The excipients observed to stabilize these proteins function by preferential hydration of the protein, and in the dry state (e.g., trehalose) may stabilize the protein via water substitution yielding a protective coating around the protein surface. Studies of other proteins should provide further insight into this mechanism of protein stabilization during encapsulation.

Formulation Aspects of Protein Stability and Complete Release in Poly(Lactic-co-glycolic acid)Microspheres

Effect of Hydrophilic/hydrophobic Additives on Protein Release from PLGA Microspheres

[Preparation of Alginate-Chitosan-poly (Lactic-Co-glycolic Acid) Composite Microsphere and Its Regulation of Protein Release].

Decoration and Application of PLGA Microspheres

A One-Step Modified Method to Reduce the Burst Initial Release from Plga Microspheres

Enhancing Foam Stability with Β-Lactoglobulin Nanoparticles: Insights into Molecular-Level Interplay and Stabilization Mechanism

Improvement of protein loading and modulation of protein release from poly(lactide-co-glycolide) microspheres by complexation of proteins with polyanions.

Recent Advances in the Preparation Progress of Protein/peptide Drug Loaded PLA/PLGA Microspheres.

Latest Research Progress of Drug Stability and Release of PLGA Microspheres

A Spheres-in-sphere Structure for Improving Protein-Loading Poly (Lactide-Co-glycolide) Microspheres

Effects of Additives and Processing Parameters on the Initial Burst Release of Protein from Poly(lactic-Co-glycolic Acid) Microspheres.

Preparation of protein-loaded sustained-release microspheres via 'solid-in-oil-in-hydrophilic oil-in-ethanol (S/O/hO/E)' emulsification

Bridging the gap between fundamental research and product development of long acting injectable PLGA microspheres

In Vitro Degradation and Controlled Release Behavior of D,L-PLGA50 and PCL-b-D,L-PLGA50 Copolymer Microspheres.

Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review

[Preparation, Characterization and Drug Release Characteristics of Poly(lactide)(pl)/poly(lactide-Co-polyethylene Glycol)(pleg) Blend Microspheres].

Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres

Release of Protein from Poly（lactide-Co-glycolide）/chitosan Dual Microspheres

Polymer-Based Sustained-Release Dosage Forms for Protein Drugs, Challenges, and Recent Advances

Preparation and Sustained-Release Performance of PLGA Microcapsule Carrier System

Microfluidic-Based Preparation of Plga Microspheres Facilitating Peptide Sustained-Release